-
-
-
-
-
-
-
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Xenon Pharmaceuticals Announces Pricing of $60.0 Million Public Offering of Common Shares
-
-
-
-
-
-
-
Notable Analyst Rating Changes 9/26: (DBD) (ETE) (ANDE) Upgraded; (DRH) (NTAP) (LYG) Downgraded
-
-
-
-
-
-
22,133 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

